Angiotensin-Converting Enzyme Inhibitor “Lisinopril” Antagonizes Hepatic TGF-β1, improving Hepatic Fibrosis Caused by Experimental Schistosomiasis mansoni

Beneficial prophylactic effects of poly(I:C) and zymosan against Schistosoma mansoni infection: MSc Thesis Abstract

BLOCKADE OF PGE2, PGD2 RECEPTORS CONFERS PROTECTION AGAINST PREPATENT SCHISTOSOMIASIS MANSONI IN MICE

Antifibrotic effect of adipose- versus bone marrow-derived mesenchymal stem cells in chronically infected mice with Schistosoma mansoni after Praziquantel treatment

THE ANTIFIBROTIC POTENTIAL OF RESVERATROL IN SCHISTOSOMA MANSONI -INFECTED MICE

Investigating Pirfenidone and Vitamin D for Targeting Cardiac and Renal Fibrotic Pathways in Experimentally-Induced Animal Model

Regulation of Liver Fibrosis during Murine Schistosomiasis Mansoni

CLOVE OIL OR COMBINED WITH PRAZIQUANTEL DOWN REGULATED TGF-Β1 AND REVERSED FIBROGENIC DYNAMIC PROGRESSION CAUSED BY CHRONIC SCHISTOSOMIASIS MANSONI IN MICE

Interferon-Α Immunotherapy, Combined with Praziquantel Downregulates VEGF Gene Expression, Causing Regression of Hepatic Fibrosis in Chronic Schistosoma Mansoni Experimental Infection

Efficacy of Pentoxifylline as an Antifibrotic Drug in Experimental Murine Schistosomal Hepatic Fibrosis